Gilead profit beats Street expectations on COVID and HIV sales
Go back to Gilead profit beats Street expectations on COVID and HIV sales| Gilead Sciences (NASDAQ: GILD) | Delayed: 150.66 -0.23 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.89 | 52 Week High | $108.63 | |||
| Open | $150.56 | 52 Week Low | $71.39 | |||
| Day High | $153.23 | P/E | 83.24 | |||
| Day Low | $149.84 | EPS | $1.81 | |||
| Volume | 2,935,076 | |||||
